Google’s DeepMind unit has used its artificial intelligence expertise to catalogue millions of ‘missense’ mutations in human DNA that may be related to the development of human diseases.

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

Google DeepMind has been making significant strides in developing ‘thinking models’—a new class of AI models that can reason, plan, and solve complex problems more effectively than previous models.